TP53 and acute myeloid leukemia: Although at very initial stages, genomic analyses of MK AML cases have consistently demonstrated that abnormalities involving chromosomes 5 [-5, or del(5q)], 7 (-7), and 17 (-17/abn(17p) are frequent in this setting, and strongly coupled to TP53 pathogenic mutations (25).